Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

MBX

MBX Biosciences, Inc.

CIK 0001776111 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$66.33
↓ 0.02 (-0.03%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$3.19B
P/E Ratio
-30.63
EPS
-2.38
Dividend Yield
Not covered
52W Position
90%
Beta
1.35

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
7.80
P/S
Not covered
EV/Revenue
Not covered
ROE
-25.5%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 90%
$9.63$72.64

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$86.97M
Total Assets
$385.14M
Free Cash Flow
-$81.88M

Recent news